<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04839705</url>
  </required_header>
  <id_info>
    <org_study_id>CL11010-001</org_study_id>
    <nct_id>NCT04839705</nct_id>
  </id_info>
  <brief_title>Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device</brief_title>
  <acronym>WEB PAS</acronym>
  <official_title>Post-Approval Study - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the WEB Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Microvention-Terumo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Microvention-Terumo, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multicenter, single arm, interventional study. The target patient population&#xD;
      for this study are adult subjects with WNBAs of the anterior and posterior intracranial&#xD;
      circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm&#xD;
      occlusion on the 1 year angiogram as adjudicated by a core laboratory.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">August 2028</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Key Effectiveness Outcome</measure>
    <time_frame>12 Months</time_frame>
    <description>Proportion of subjects with adequate aneurysm occlusion at one year after treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Key Safety Outcome</measure>
    <time_frame>12 Months</time_frame>
    <description>Proportion of subjects with death of any nonaccidental cause or any major stroke* within the first 30 days after treatment or major ipsilateral stroke or death due to neurologic cause from day 31 to the 1 year after treatment</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Wide Neck Bifurcation Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>WEB Aneurysm Embolization Device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>WEB Aneurysm Embolization Device The WEB is an intra-aneurysmal device intended for use in endovascular embolization of intracranial aneurysms. The intended therapeutic effect of the WEB device is to line the neck of the aneurysm with a metallic structure that disrupts the inflow of blood, causing hemostasis within the aneurysm sac, and leading to thrombus formation within the implant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WEB</intervention_name>
    <description>Device: WEB The WEB is an intra-aneurysmal device intended for use in endovascular embolization of intracranial aneurysms.&#xD;
Other Names:&#xD;
• WEB Aneurysm Embolization Device</description>
    <arm_group_label>WEB Aneurysm Embolization Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Patient must be ≥ 18 at the time of screening&#xD;
&#xD;
          -  Patient must have a single ruptured or unruptured IA requiring treatment&#xD;
&#xD;
          -  Patient must sign and date an IRN approved written informed consent prior to&#xD;
             initiation of any study procedures&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Patient has an IA with characteristics unsuitable for endovascular treatment&#xD;
&#xD;
          -  Patient has conditions placing them at high risk for ischemic stroke or has exhibited&#xD;
             ischemic symptoms such as transient ischemic attacks, minor strokes, or&#xD;
             stroke-in-evolution within the prior 30 days&#xD;
&#xD;
          -  Patient has had an SAH from a non-index IA or other intracranial hemorrhage within 90&#xD;
             days&#xD;
&#xD;
          -  Patient index IA was previously treated&#xD;
&#xD;
          -  Patient is pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Arthur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Methodist University Hospital, Memphis TN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Fiorella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stony Brook University, Stony Brook NY</affiliation>
  </overall_official>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>April 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aneurysm</keyword>
  <keyword>Intracranial Arterial Disease</keyword>
  <keyword>Cerebrovascular Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

